Anabolic bone therapies in 2014: New bone-forming treatments for osteoporosis

Nature reviews. Endocrinology

Volumn 11, Issue 2, 2015, Pages 69-70

  Papapoulos, Socrates E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT; BONE MORPHOGENETIC PROTEIN; GENETIC MARKER; MONOCLONAL ANTIBODY; PARATHYROID HORMONE[1-34]; ROMOSOZUMAB; SOST PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; BONE DENSITY; DRUG EFFECTS; FEMALE; GENETIC MARKER; HUMAN; OSTEOPOROSIS;

ANTIBODIES, MONOCLONAL; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE MORPHOGENETIC PROTEINS; FEMALE; GENETIC MARKERS; HUMANS; OSTEOPOROSIS; TERIPARATIDE;

EID: 84923114846     PISSN: None     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2014.214     Document Type: Article

References (0)